Shijiazhuang, China

Shixia Wang

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 9.6

ph-index = 1


Location History:

  • Shijiazhuang, CN (2019)
  • Hebei, CN (2023)

Company Filing History:


Years Active: 2019-2023

where 'Filed Patents' based on already Granted Patents

2 patents (USPTO):

Title: Shixia Wang: Innovator in Pharmaceutical Technology

Introduction

Shixia Wang is a notable inventor based in Shijiazhuang, China. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of innovative treatments for lymphoma. With a total of 2 patents, his work has the potential to impact cancer therapy significantly.

Latest Patents

Wang's latest patents include the use of mitoxantrone liposome for treating non-Hodgkin's lymphoma. This patent discloses a liposomal pharmaceutical preparation of mitoxantrone designed specifically for treating lymphoma, with a focus on aggressive non-Hodgkin's lymphoma. The invention emphasizes the use of mitoxantrone liposomes as a single anti-tumor therapeutic agent, without the need for combination with other anti-tumor agents.

Another significant patent by Wang involves purified therapeutic nanoparticles and their preparation methods. These nanoparticles consist of an active pharmaceutical ingredient and human serum albumin, with a specific weight ratio. The invention also includes pharmaceutical compositions that are substantially free of free human serum albumin, enhancing the therapeutic efficacy of the nanoparticles.

Career Highlights

Shixia Wang has worked with prominent companies in the pharmaceutical sector, including Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. and Cspc Zhongqi Pharmaceutical Technology Co., Ltd. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Wang has collaborated with notable colleagues such as Chunlei Li and Yajuan Wang. These partnerships have likely fostered a collaborative environment that encourages innovation and the advancement of pharmaceutical technologies.

Conclusion

Shixia Wang's contributions to pharmaceutical technology, particularly in the treatment of lymphoma, highlight his role as an influential inventor. His patents reflect a commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…